Universität Wien

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2022W)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung
Moodle

Details

Sprache: Englisch

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

03.10.2022 13:15-16:00 HS7 Welcome Address, Introduction of the Faculty and the Program TL
04.10.2022 13:15-16:30 2D313 Innovation in Drug Discovery SDB
05.10.2022 14:00-17:00 2D313 Drugs from Traditional Medicine JMR
06.10.2022 14:00-17:00 2D313 Chemistry Driven Drug Discovery TL
10.10.2022 14:00-17:00 2D313 Screening in Drug Discovery KO
11.10.2022 13:00-14:30 2D313 Introduction to formulation science and pre-clinical development LAD
11.10.2022 15:00-16:30 2D313 Introduction to quality-by-design LAD
12.10.2022 14:00-17:00 2D313 Drugs from Traditional Medicine (Student Presentations I) JR / SDB
13.10.2022 14:00-17:00 2D313 Drugs from Traditional Medicine (Student Presentations II) JR / SDB
17.10.2022 14:00-17:00 2D313 Screening in Drug Discovery (Student Presentations) KO / SDB
18.10.2022 13:00-15:00 2D313 Target Product Profiles (Student Presentations) LAD / SDB
19.10.2022 14:00-17:00 2D313 Chemistry Driven Drug Discovery (Student Presentations I) TL / SDB
20.10.2022 14:00-17:00 2D313 Chemistry Driven Drug Discovery (Student Presentations II) TL / SDB
24.10.2022 14:00-17:00 2D313 Screening in Drug Discovery, Laboratory Exercise 323002 (UE) KO
27.10.2022 13:15-16:30 2D313 Written Evaluation TL / SDB

  • Montag 03.10. 13:15 - 16:30 UZA2 Hörsaal 7 (Raum 2Z210) 2.OG

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the
material collected during the class and the studies for the class.

Mindestanforderungen und Beurteilungsmaßstab

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.

Prüfungsstoff

All topics covered during the course.

Literatur

Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Mi 21.09.2022 14:28